ISSUP Nigeria Chapter has scheduled her Annual Conference/General Meeting for Tuesday the 26th of October 2021.
Dr Ngozi Madubuike
Professor Michael Exenwa
Ambassador Christogonus C. Ibe
Dr Bassey Edet
Professor Michael Ezenwa
Dr Musa Shehu Dan Daura
The next European Conference on Addictive Behaviours and Dependencies will take place from 23-25 November 2022.
The overarching theme of Lisbon Addictions 2022 will be Global Addictions.
The following issues will be the focus of the conference:
The Annual International Society of Addiction Medicine (ISAM) Conference will be virtual between November 19 and November 21, 2021.
This global event is dedicated to providing world-class addiction medicine education and provides an exceptional opportunity to highlight new research, innovative practices, sociopolitical ideas, and new approaches to treatment.
ICARA is the International Confederation of Alcohol, Tobacco and other Drug (ATOD) Research Associations. It is an umbrella organisation for research societies across the globe concerned about alcohol, tobacco, other drugs and behavioural addictions.
The APSAD Conference provides an opportunity for networking and idea sharing in a friendly and informal atmosphere with a cross-section of AOD workers; practitioners, researchers, peer workers, consumers, and policymakers.
The conference also contributes to building capacity and capability in AOD by providing opportunities for engagement and learnings from early to mid-career, and more experienced researchers and clinicians.
By the end of this webinar, attendees will be able to:
The first intersessional meeting of the 64th session of the Commission will take place from 19-21 October 2021 and will include thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration
The U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL) presents the third annual event on partnering with the private sector to address the world drug problem.
The private sector can play a major role in preventing and combating the manufacture, diversion, sale, and misuse of drugs and precursors by mobilizing its unique resources, technologies, and expertise.